Abstract
Various peptides have been used extensively to prepare selective drug delivery carriers due to the ability to target specific cells and to be selectively degraded by various biostimulants. Furthermore, nanocarriers capable of controlled drug release could be prepared by employing the triggered conformational transformation of peptides by specific biostimulation. Here, a cyclic peptide gatekeeper with an HAV sequence, known to specifically bind to N-cadherin, is introduced on the surface of mesoporous nanocarriers. The drug release from the nanocarriers is completely inhibited in the absence of external stimuli. In the presence of specific biostimuli, the cyclic peptide gatekeeper is transformed, and the encapsulated drugs in the nanocarriers are released on demand.
Similar content being viewed by others
References
Alberti S, Soler-Illia GJAA, Azzaroni O (2015) Gated supramolecular chemistry in hybrid mesoporous silica nanoarchitectures: Controlled delivery and molecular transport in response to chemical, physical and biological stimuli. Chem Commun 51(28):6050–6075
Aznar E, Oroval M, Pascual L, Murguía JR, Martínez-Máñez R, Sancenón F (2016) Gated materials for on-command release of guest molecules. Chem Rev 116(2):561–718
Balendiran GK, Dabur R, Fraser D (2004) The role of glutathione in cancer. Cell Biochem Funct 22(6):343–352
Coll C, Mondragón L, Martínez-Máñez R, Sancenón F, Marcos MD, Soto J, Amorós P, Pérez-Payá E (2011) Enzyme-mediated controlled release systems by anchoring peptide sequences on mesoporous silica supports. Angew Chem Int Ed 50(9):2138–2140
Coll C, Bernardos A, Martínez-Máñez R, Sancenón F (2013) Gated silica mesoporous supports for controlled release and signaling applications. Acc Chem Res 46(2):339–349
Colombo G, Curnis F, De Mori GMS, Gasparri A, Longoni C, Sacchi A, Longhi R, Corti A (2002) Structure-activity relationships of linear and cyclic peptides containing the NGR tumor-homing motif. J Biol Chem 277(49):47891–47897
Copolovici DM, Langel K, Eriste E, Langel Ü (2014) Cell-penetrating peptides: design, synthesis, and applications. ACS Nano 8(3):1972–1994
Estrela JM, Ortega A, Obrador E (2006) Glutathione in cancer biology and therapy. Crit Rev Clin Lab Sci 43(2):143–181
Fields GB, Noble RL (1990) Solid phase peptide synthesis utilizing 9-fluorenylmethoxycarbonyl amino acids. Int J Pept Protein Res 35(3):161–214
Kim H, Kim S, Park C, Lee H, Park HJ, Kim C (2010) Glutathione-induced intracellular release of guests from mesoporous silica nanocontainers with cyclodextrin gatekeepers Adv. Mater 22(38):4280–4283
Kresge CT, Leonowicz ME, Roth WJ, Vartuli JC, Beck JS (1992) Ordered mesoporous molecular sieves synthesized by a liquid-crystal template mechanism. Nature 359(6397):710–712
Lee J, Kim H, Kim S, Lee H, Kim J, Kim N, Park HJ, Choi EK, Lee JS, Kim C (2012) A multifunctional mesoporous nanocontainer with an iron oxide core and a cyclodextrin gatekeeper for an efficient theranostic platform. J Mater Chem 22(28):14061–14067
Lee J, Kim H, Han S, Hong E, Lee K-H, Kim C (2014) Stimuli-responsive conformational conversion of peptide gatekeepers for controlled release of guests from mesoporous silica nanocontainers. J Am Chem Soc 136(37):12880–12883
Lee J, Kim H, Kim C (2016a) Generation dependency of stimuli-responsive dendron-gated mesoporous silica nanocontainers. Macromol Res 24(5):478–481
Lee J, Oh E-T, Yoon H, Kim H, Park HJ, Kim C (2016b) A mesoporous nanocontainer gated by stimuli-responsive peptide for selective triggering of intracellular drug release. Nanoscale 8(15):8070–8077
Lee J, Han S, Lee J, Choi M, Kim C (2017a) Stimuli-responsive α-helical peptide gatekeepers for mesoporous silica nanocarriers. New J Chem 41(15):6969–6972
Lee J, Oh E-T, Han Y, Kim HG, Park HJ, Kim C (2017b) Mesoporous silica nanocarriers with cyclic peptide gatekeeper: Specific targeting of aminopeptidase n and triggered drug release by stimuli-responsive conformational transformation. Chem Eur J 23(67):16966–16971
Lee J, Oh E-T, Song J, Kim HG, Park HJ, Kim C (2017c) Stimulus-induced conformational transformation of cyclic peptide for selective cell targeting on-off gatekeeper of mesoporous nanocarrier. Chem Asian J 12(21):2813–2818
Lee J, Oh E-T, Yoon H, Kim CW, Han Y, Song J, Jang H, Park HJ, Kim C (2017d) Mesoporous nanocarriers with stimulus-responsive cyclodextrin gatekeeper for targeting tumor hypoxia. Nanoscale 9(20):6901–6909
Lee J, Oh E-T, Choi MH, Kim HG, Park HJ, Kim C (2018) Dual-functional cyclic peptide switch on mesoporous nanocontainers for selective cd44 targeting and on-off gatekeeping triggered by conformational transformation. New J Chem 42(15):12938–12944
Lee J, Oh E-T, Lee J, Kang T, Kim HG, Kang H, Park HJ, Kim C (2019) Cyclic irgd peptide as a dual-functional on-off gatekeeper of mesoporous nanocontainers for targeting nrp-1 and selective drug release triggered by conformational conversion. New J Chem 43(3):1517–1522
Liu H, Wang H, Shenvi S, Hagen TM, Liu R-M (2004) Glutathione metabolism during aging and in Alzheimer disease. Ann NY Acad Sci 1019:346–349
Majhen D, Gabrilovac J, Eloit M, Richardson J, Ambriović-Ristov A (2006) Disulfide bond formation in NGR fiber-modified adenovirus is essential for retargeting to aminopeptidase n. Biochem Biophys Res Commun 348(1):278–287
Mrozik KM, Blaschuk OW, Cheong CM, Zannettino ACW, Vandyke K (2018) N-cadherin in cancer metastasis, its emerging role in haematological malignancies and potential as a therapeutic target in cancer. BMC Cancer 18(1):939
Mura S, Nicolas J, Couvreur P (2013) Stimuli-responsive nanocarriers for drug delivery. Nat Mater 12:991–1003
Paris JL, Cabañas MV, Manzano M, Vallet-Regí M (2015) Polymer-grafted mesoporous silica nanoparticles as ultrasound-responsive drug carriers. ACS Nano 9(11):11023–11033
Park C, Kim H, Kim S, Kim C (2009) Enzyme responsive nanocontainers with cyclodextrin gatekeepers and synergistic effects in release of guests. J Am Chem Soc 131(46):16614–16615
Shintani Y, Fukumoto Y, Chaika N, Grandgenett PM, Hollingsworth MA, Wheelock MJ, Johnson KR (2008) Adh-1 suppresses n-cadherin-dependent pancreatic cancer progression. Int J Cancer 122(1):71–77
Slowing II, Vivero-Escoto JL, Wu C-W, Lin VSY (2008) Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers. Adv Drug Deliv Rev 60(11):1278–1288
Tanaka H, Kono E, Tran CP, Miyazaki H, Yamashiro J, Shimomura T, Fazli L, Wada R, Huang J, Vessella RL, An J, Horvath S, Gleave M, Rettig MB, Wainberg ZA, Reiter RE (2010) Monoclonal antibody targeting of n-cadherin inhibits prostate cancer growth, metastasis and castration resistance. Nat Med 16(12):1414–1420
Tang F, Li L, Chen D (2012) Mesoporous silica nanoparticles: synthesis, biocompatibility and drug delivery. Adv Mater 24(12):1504–1534
Thornton PD, Heise A (2010) Highly specific dual enzyme-mediated payload release from peptide-coated silica particles. J Am Chem Soc 132:2024–2028
Verrier S, Pallu S, Bareille R, Jonczyk A, Meyer J, Dard M, Amédée J (2002) Function of linear and cyclic RGD-containing peptides in osteoprogenitor cells adhesion process. Biomaterials 23(2):585–596
Vivero-Escoto JL, Slowing II, Wu C-W, Lin VSY (2009) Photoinduced intracellular controlled release drug delivery in human cells by gold-capped mesoporous silica nanosphere. J Am Chem Soc 131(10):3462–3463
Vivero-Escoto JL, Slowing II, Trewyn BG, Lin VSY (2010) Mesoporous silica nanoparticles for intracellular controlled drug delivery. Small 6(18):1952–1967
Wen J, Yang K, Liu F, Li H, Xu Y, Sun S (2017) Diverse gatekeepers for mesoporous silica nanoparticle based drug delivery systems. Chem Soc Rev 46(19):6024–6045
Williams E, Williams G, Gour BJ, Blaschuk OW, Doherty P (2000) A novel family of cyclic peptide antagonists suggests that n-cadherin specificity is determined by amino acids that flank the hav motif*. J Biol Chem 275(6):4007–4012
Zhang J, Yuan Z-F, Wang Y, Chen W-H, Luo G-F, Cheng S-X, Zhuo R-X, Zhang X-Z (2013) Multifunctional envelope-type mesoporous silica nanoparticles for tumor-triggered targeting drug delivery. J Am Chem Soc 135(13):5068–5073
Acknowledgements
This work was supported by the National Research Foundation of Korea (NRF-2021R1C1C2011651). C.K thanks Inha University for support.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Lee, J., Kim, K. & Kim, C. Mesoporous nanocarriers with cyclic peptide gatekeeper containing N-cadherin binding sequence for stimulus-responsive drug release. Chem. Pap. 76, 6801–6807 (2022). https://doi.org/10.1007/s11696-022-02367-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11696-022-02367-x